VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $1.1M invested in VYNE Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 19

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$85.6K
2
+$61.4K
3
+$52.7K
4
HF
HRT Financial
New York
+$31K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$797

Top Sellers

1
-$166K
2
-$69.7K
3
-$20.2K
4
CAN
Cetera Advisor Networks
California
-$17.3K
5
Franklin Resources
Franklin Resources
California
-$14.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
1
2